Dr. Ann Navar, MD
Not yet claimedPreventive cardiologist, Cardiologist, Lipidologist, Hypertension specialist · Physician (MD)
Dallas, TX · Telehealth in 1 state
Board-certified cardiologist and Professor of Internal Medicine and Population and Data Sciences at UT Southwestern who joined the faculty in 2020 and specializes in preventive cardiology, dyslipidemia and hypertension; her research centers on cardiovascular prevention, real-world data and risk prediction.
About Dr. Ann Navar, MD
Updated Sep 20, 2026 · next review Dec 19, 2026Dr. Ann Marie Navar is a board-certified cardiologist in Dallas, Texas, who focuses on preventive cardiology, cholesterol (lipid) care, and high blood pressure. She joined the faculty at UT Southwestern Medical Center in 2020 and is listed by her institution as an Associate Professor of Internal Medicine and of Population and Data Sciences. She sees patients through UT Southwestern, including clinic sites at UTSW RedBird and West Campus Building 3, and is affiliated with William P. Clements Jr. University Hospital and Parkland Health.
Her training includes a medical degree from Duke University School of Medicine, an internal medicine and pediatrics residency at Duke, and a cardiology fellowship at Duke with a research fellowship at the Duke Clinical Research Institute. She also holds a PhD in global disease epidemiology and control and an MHS from the Johns Hopkins Bloomberg School of Public Health.
Much of her public work is in research and national guideline writing on cholesterol and heart disease prevention. She was a writing committee member for the 2026 ACC/AHA multisociety guideline on managing dyslipidemia, serves as an editor at JAMA Cardiology, and is a board member and Treasurer of the American Society for Preventive Cardiology. She has been quoted in medical news coverage explaining new guideline recommendations, including universal Lp(a) testing and LDL cholesterol goals after a heart event.
Federal Open Payments records list $453,686.03 in industry payments to her across 252 records from 2021 to 2025, with the largest amounts from Eli Lilly, Novo Nordisk, Merck Sharp & Dohme, Bayer HealthCare Pharmaceuticals, and Amgen. Payments from drug and device companies to physicians are common, legal, and publicly reported.
- Board-certified cardiologist
- She is board certified in cardiovascular disease and joined the UT Southwestern faculty in 2020. utswmed.org
- National cholesterol guideline author
- She was a writing committee member for the 2026 ACC/AHA multisociety Guideline on the Management of Dyslipidemia. jacc.org
- Duke training in medicine and cardiology
- She earned her MD at Duke University School of Medicine and completed an internal medicine/pediatrics residency and cardiology fellowship there. utswmed.org
- PhD in epidemiology
- She holds a PhD in global disease epidemiology and control and an MHS from the Johns Hopkins Bloomberg School of Public Health. utswmed.org
- Medical journal editor
- She was named an Associate Editor of JAMA Cardiology and serves as Deputy Editor for Equity, Diversity and Inclusion at the journal. medicine.duke.edu
- Preventive cardiology society leader
- She is a board member and Treasurer of the American Society for Preventive Cardiology. aspconline.org
- Research on statins and cholesterol
- Her published work includes a review on apolipoprotein B particles and cardiovascular disease and a qualitative study of clinician and patient views on statin therapy and side effects. pmc.ncbi.nlm.nih.gov
- Award for clinical research
- Her institutional profile lists the Jeremiah Stamler Award for Faculty Clinical Research among her honors. utswmed.org
- Work on access to cardiology care
- She has been involved with "Doctors With Heart," an American Heart Association initiative on cardiology access in under-resourced communities. radcliffecardiology.com
- Industry payments on record
- CMS Open Payments lists $453,686.03 across 252 records from 2021 to 2025, with the largest totals from Eli Lilly ($187,070.61) and Novo Nordisk ($115,149.65). openpaymentsdata.cms.gov
Worth knowing
- Federal Open Payments data show $453,686.03 in payments from drug companies between 2021 and 2025, including from makers of cholesterol and metabolic medicines such as Eli Lilly, Novo Nordisk, Merck, Bayer, and Amgen. Such payments are common and legal, and patients may wish to ask how they relate to treatment recommendations. openpaymentsdata.cms.gov
- Her current academic title is listed by UT Southwestern as Associate Professor, which differs from "Professor" as shown in some other listings. profiles.utsouthwestern.edu
- An Instagram account under the handle @annmarienavar appears to match her name, but the account content could not be independently verified, so the attribution is probable rather than confirmed. instagram.com
Industry payments (CMS Open Payments)
Open the CMS recordFederal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.
2021 to 2025
$453,686
252 payments
| 2021 | $46,770 |
| 2022 | $67,542 |
| 2023 | $79,348 |
| 2024 | $164,909 |
| 2025 | $95,117 |
Top payers
- Eli Lilly and Company$187,071
- Novo Nordisk AS$115,150
- Merck Sharp & Dohme LLC$32,272
- Bayer HealthCare Pharmaceuticals Inc.$15,850
- Amgen Inc.$14,297
Payment types
- Consulting Fee$349,591
- Travel and Lodging$86,817
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$10,000
- Food and Beverage$5,238
- Honoraria$1,635
A word of caution about these numbers
A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.
As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.
Sources: utswmed.org · profiles.utsouthwestern.edu · cme.utsouthwestern.edu · x.com · instagram.com · aspconline.org · radcliffecardiology.com · esc365.escardio.org. Something wrong or out of date? Tell us and we will correct it.
Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.
Practice location
UT Southwestern Clinical Heart and Vascular Center
2001 Inwood Road, 5th Floor
Dallas, TX 75390
Open in maps